30/04/2019 Drug Result Page - MICROMEDEX

Ranitidine Hydrochloride [Sua pesquisa: Ranitidine]

Drug Classes: Antiulcer | Gastric Acid Secretion Inhibitor | All
Routes: Injection | Oral

Dosing/Administration Dosing/Administration
Imprimir
Adult Dosing Administration
Pediatric Dosing
Intramuscular
FDA Uses
No dilution is necessary [5].
Non-FDA Uses
Dose Adjustments Intravenous
Administration (Injection for intermittent bolus) Dilute ranitidine 50 mg (2 mL) in NS or
Comparative Efficacy other compatible IV solution to a concentration no greater than 2.5 mg/mL
(20 mL) and inject at a rate no greater than 4 mL/min (usually 5 minutes)
Place In Therapy [5].

Medication Safety (Injection for intermittent infusion) Dilute ranitidine 50 mg (2 mL) in D5W or
other compatible IV solution to a concentration no greater than 0.5 mg/mL
Contraindications
(100 mL) and infuse at a rate no greater than 5 to 7 mL/min (usually 15 to
Precautions 20 minutes) [5].
Adverse Effects (Injection for continuous infusion) Dilute in D5W or other compatible IV
solution and infuse at a rate of 6.25 mg/hr [5].
Black Box Warning
(Injection for continuous infusion) For Zollinger-Ellison patients, dilute in
REMS
D5W or other compatible IV solution to a concentration no greater than 2.5
Drug Interactions (single) mg/mL; start infusion at a rate of 1 mg/kg/hr [5].
IV Compatibility (single) Stable for 48 hours at room temperature when added to or diluted with
Pregnancy & Lactation most commonly used IV solutions [5]

Monitoring
Do Not Confuse

Mechanism of Action
Mechanism of Action

Pharmacokinetics
Pharmacokinetics

Patient Education
Medication Counseling
Patient Handouts

Toxicology
Clinical Effects
Range of Toxicity
Treatment

About
How Supplied
Drug Properties

https://www.micromedexsolutions.com/micromedex2/librarian/PFDefaultActionId/evidencexpert.DoIntegratedSearch?navitem=topHome&isToolPa… 1/2